Attachment 4
ERB approval
Date: October 17, 2024
From: Catherine Simile, Ph.D.
Chair, NCHS ERB
Kimberly Daniels, Ph.D.
Vice Chair, NCHS ERB
To: Duong Nguyen, DO
Alan Simon, MD
Subject: Protocol #2024-01 NHANES 2025-2026 - Amendment #1 NHANES DXA and Hematology Crossover studies (OCD20240812.01)
The NCHS Human Subjects Contact determined that Protocol #2024-01 NHANES 2025-2026 - Amendment #1 NHANES DXA and Hematology Crossover studies, is a public health surveillance activity under the 2018 requirements of the Common Rule (45 CFR 46.102(l)(2)).
The NCHS Ethics Review Board reviewed the request for approval of Protocol #2024-01 NHANES 2025-2026 - Amendment #1 NHANES DXA and Hematology Crossover studies (OCD20240812.01), using the expedited review process based on 46.110 of 45 CFR 46(b)(2), minor change to previously approved protocol.
Description of proposed modification:
Amendment #1 NHANES DXA and Hematology Crossover studies
Protocol #2024-01 NHANES 2025-2026 - Amendment #1 NHANES DXA and Hematology Crossover studies is approved.
Any problems of a serious nature should be brought to the attention of the ERB, and any additional proposed changes should be submitted for ERB approval before they are implemented.
Please contact me or Kyle Wise if you have any questions.
Catherine Simile, Ph.D.
Chair, NCHS ERB
Kimberly Daniels, Ph.D.
Vice Chair, NCHS ERB
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Ogburn, Damon (CDC/IOD/OPHDST/NCHS) |
| File Modified | 0000-00-00 |
| File Created | 2025-01-14 |